SVRA
Savara Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -18.2% ·
share flow -30.0% ·
net new positions -20.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | -4 | 57.38M | $353.31M | +4 | −8 |
| Q1 2026 | 80 | +17 | 56.36M | $307.68M | +21 | −4 |
| Q4 2025 | 62 | -1 | 53.03M | $319.78M | +1 | −2 |
| Q3 2025 | 16 | +2 | 30.07M | $107.34M | +2 | n/a |
| Q2 2025 | 11 | -1 | 28.07M | $64.00M | n/a | −1 |
| Q1 2025 | 9 | -2 | 11.30M | $31.31M | n/a | −2 |
| Q4 2024 | 11 | +2 | 17.17M | $52.72M | +2 | n/a |
| Q3 2024 | 8 | -1 | 19.41M | $82.32M | +1 | −2 |
| Q2 2024 | 9 | n/a | 17.54M | $70.68M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.16M | -24.1% | $11.53M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 2 | Geode Capital Management ✦ (passive) | 2.82M | +1.4% | $7.82M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | State Street Global Advisors ✦ (passive) | 2.45M | -41.3% | $6.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 797.33K | +13.7% | $2.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 504.01K | +190.7% | $1.40M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Two Sigma Investments ✦ | 405.60K | -48.4% | $1.12M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 56.26K | -20.3% | $155,840 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 52.12K | +19.4% | $145,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 52.21K | -89.2% | $144,619 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Adage Capital Partners | $6.50M | was 0.0% |
| Marshall Wace | $1.11M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 185 holders, 212.23M shares, $1.16B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.